Russell H. Tomar

1.6k total citations
56 papers, 1.2k citations indexed

About

Russell H. Tomar is a scholar working on Immunology, Virology and Molecular Biology. According to data from OpenAlex, Russell H. Tomar has authored 56 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 11 papers in Virology and 9 papers in Molecular Biology. Recurrent topics in Russell H. Tomar's work include HIV Research and Treatment (11 papers), Immune Cell Function and Interaction (7 papers) and Immune Response and Inflammation (7 papers). Russell H. Tomar is often cited by papers focused on HIV Research and Treatment (11 papers), Immune Cell Function and Interaction (7 papers) and Immune Response and Inflammation (7 papers). Russell H. Tomar collaborates with scholars based in United States, India and Canada. Russell H. Tomar's co-authors include John D. Reveille, Daniel H. Solomon, Henry A. Homburger, Arthur Kavanaugh, Bruce E. Kloster, Fletcher B. Taylor, Timothy L. Darrow, David F. Keren, Peter D. Gorevic and James A. Goeken and has published in prestigious journals such as Nature, Blood and The Journal of Immunology.

In The Last Decade

Russell H. Tomar

52 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Russell H. Tomar United States 17 542 267 231 230 193 56 1.2k
P M Lydyard United Kingdom 20 1000 1.8× 205 0.8× 231 1.0× 173 0.8× 300 1.6× 49 1.6k
Stephen D. Litwin United States 24 729 1.3× 140 0.5× 386 1.7× 349 1.5× 459 2.4× 91 1.8k
Armead H. Johnson United States 20 830 1.5× 280 1.0× 230 1.0× 294 1.3× 168 0.9× 43 1.6k
Nicolás Bianco Venezuela 20 633 1.2× 321 1.2× 152 0.7× 89 0.4× 138 0.7× 73 1.3k
Arthur W. Boylston United Kingdom 24 1.4k 2.5× 183 0.7× 359 1.6× 90 0.4× 297 1.5× 67 2.1k
Chihiro Terai Japan 20 462 0.9× 343 1.3× 73 0.3× 150 0.7× 555 2.9× 83 1.6k
P. Györkey United States 22 258 0.5× 210 0.8× 100 0.4× 68 0.3× 377 2.0× 39 1.6k
Chester M. Zmijewski United States 21 882 1.6× 92 0.3× 174 0.8× 177 0.8× 236 1.2× 78 1.7k
Massimo Fiorilli Italy 28 1.1k 2.0× 328 1.2× 98 0.4× 204 0.9× 468 2.4× 118 2.5k
Nelson F. Mendes Brazil 14 728 1.3× 73 0.3× 154 0.7× 149 0.6× 171 0.9× 42 1.4k

Countries citing papers authored by Russell H. Tomar

Since Specialization
Citations

This map shows the geographic impact of Russell H. Tomar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell H. Tomar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell H. Tomar more than expected).

Fields of papers citing papers by Russell H. Tomar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell H. Tomar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell H. Tomar. The network helps show where Russell H. Tomar may publish in the future.

Co-authorship network of co-authors of Russell H. Tomar

This figure shows the co-authorship network connecting the top 25 collaborators of Russell H. Tomar. A scholar is included among the top collaborators of Russell H. Tomar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell H. Tomar. Russell H. Tomar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keren, David F., Raymond Alexanian, James A. Goeken, et al.. (1999). Guidelines for Clinical and Laboratory Evaluation of Patients With Monoclonal Gammopathies. Archives of Pathology & Laboratory Medicine. 123(2). 106–107. 82 indexed citations
2.
Tomar, Russell H.. (1999). Total Laboratory Automation and Diagnostic Immunology. Clinical and Diagnostic Laboratory Immunology. 6(3). 293–294. 7 indexed citations
3.
Tomar, Russell H.. (1994). Breaking the asymptomatic phase of HIV‐1 infection. Journal of Clinical Laboratory Analysis. 8(2). 116–119. 8 indexed citations
4.
Tomar, Russell H., et al.. (1992). Sera from simian immunodeficiency virus‐infected rhesus macaques inhibit lymphocyte proliferation. Journal of Clinical Laboratory Analysis. 6(5). 297–301. 1 indexed citations
5.
Sacks, Leonard, et al.. (1991). A Streptococcal Erythrogenic Toxin Preparation Augments Natural Killer Activity of Peripheral Blood Mononuclear Cells. The Journal of Infectious Diseases. 164(3). 522–526. 4 indexed citations
6.
Tomar, Russell H., et al.. (1990). Serum factors in the progression of human immunodeficiency virus type 1 infection to aids. Journal of Clinical Laboratory Analysis. 4(3). 218–223. 4 indexed citations
7.
Yuille, Martin, Margaret Hugunin, LYNDON A. PEER, et al.. (1988). HIV-1 infection abolishes CD4 biosynthesis but not CD4 mRNA.. PubMed. 1(2). 131–7. 14 indexed citations
8.
Kloster, Bruce E., et al.. (1987). Soluble interleukin 2 receptors are elevated in patients with AIDS or at risk of developing AIDS. Clinical Immunology and Immunopathology. 45(3). 440–446. 63 indexed citations
9.
Lapham, Cheryl, et al.. (1986). The mechanism of enhancement of natural killer cell activity by soluble streptococcal products. Clinical Immunology and Immunopathology. 40(2). 335–346. 4 indexed citations
10.
Zamkoff, Kenneth W., et al.. (1985). Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease. Clinical Immunology and Immunopathology. 35(1). 111–124. 18 indexed citations
11.
Tomar, Russell H., David Nelson, Peter John, & BJ Poiesz. (1985). 341 Patients with selective IgA deficiency/at have anti HTLV 1-MA antibodies. Journal of Allergy and Clinical Immunology. 75(1). 190–190. 1 indexed citations
12.
Kloster, Bruce E., Janet Moore, Russell H. Tomar, et al.. (1984). Efficient transformation of previously activated and dividing T lymphocytes by human T cell leukemia-lymphoma virus. Blood. 64(5). 967–974. 46 indexed citations
13.
Stockman, J.A., Bruce E. Kloster, Russell H. Tomar, John G. Kelton, & David Groth. (1984). SPECTRUM OF IMMUNOLOGIC ABNORMALITIES IN SUBJECTS WITH HEMOPHILIA. Pediatric Research. 18. 249A–249A.
14.
Tomar, Russell H.. (1981). Predicting Acute vs Chronic Childhood Idiopathic Thrombocytopenic Purpura. Archives of Pediatrics and Adolescent Medicine. 135(5). 446–446. 7 indexed citations
15.
Tomar, Russell H., et al.. (1980). Human T lymphcytes are enriched for transfer factor.. The Journal of Immunology. 124(3). 1054–1057.
16.
Pinals, Robert S., et al.. (1979). Treatment of rheumatoid arthritis with levamisole: long-term results and immune changes.. Annals of the Rheumatic Diseases. 38(2). 122–127. 11 indexed citations
17.
Tomar, Russell H.. (1976). Delayed Skin Reactor from Streptokinase-Streptodornase: Stability Studies and Amino Acid Analysis. International Archives of Allergy and Immunology. 50(2). 220–224. 4 indexed citations
18.
Neu, RichardL., J.A. Stockman, Roxane Spitzer, & Russell H. Tomar. (1976). 46,XY/46,XY,21q- mosaicism in an infant with neutropenia and properdin deficiency.. Journal of Medical Genetics. 13(4). 332–334. 8 indexed citations
19.
Tomar, Russell H., et al.. (1972). Delayed Hypersensitivity to SK-SD: In Vitro Lymphocyte Study with an Active Component. The Journal of Immunology. 108(1). 231–235. 11 indexed citations
20.
Green, Gary, et al.. (1971). Separation of a material in streptokinase-streptodornase which induces delayed skin reaction. Journal of Allergy and Clinical Immunology. 48(1). 23–27. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026